Medical
Neocis began selling Yomi widely at the start of 2018.
A dated step forward on the record · Company-reported
What the source says
“Neocis received FDA clearance for Yomi in 2016 and began its commercial push at the start of 2018.”
What it means
Yomi, from Neocis, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Its stage is set by other milestones on its record; this one adds to the history. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.
Human help: Our sources report it working without human help.
More on Yomi
- Neocis said clinicians had done more than 100,000 implant drillings with Yomi.
- The FDA cleared Yomi S, a next-generation version, through the 510(k) route (K252376). Neocis launched it in November 2025; one person can run it with a foot pedal and touchscreen.
- Neocis raised about $70 million in a round led by DFJ Growth.
- Neocis said more than 2,700 procedures had been done with Yomi in 50 US cities.
- The FDA cleared Neocis's guidance system, later sold as Yomi, through the 510(k) route (K161399). Neocis says it was the first robot cleared for dental implant surgery.